Q4 2023 Enfusion Inc Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Enfusions Fourth Quarter and Full Year 2023 earnings conference call. (Operator Instructions)
As a reminder, this conference call is being recorded. I'd now like to turn the call over to Bill Wright, Head of Investor Relations, to begin.
Good morning, and thank you, operator. We welcome you to Enfusions Fourth Quarter and Full Year 2023 earnings conference call. Hosting today's call are Oleg Movchan, Enfusion's Chief Executive Officer; Brad Herring, Fusion's Chief Financial Officer, and Neal Pawar, Enfusions' newly appointed Chief Operating Officer.
Please note our quarterly shareholder letter, which includes our quarterly financial results, has been posted to our Investor Relations website. I would like to remind you that today's call may contain forward looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC which are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |